Answer in brief
CVE-2020-27575 records a High severity (CVSS 8.8) command injection vulnerability in CVE-2020-27575. The source record does not mark it as known exploited. No package mapping is present, so exposure must be confirmed against the affected product and deployment inventory.
Answer in brief
CVE-2020-27575 records a High severity (CVSS 8.8) command injection vulnerability in CVE-2020-27575. The source record does not mark it as known exploited. No package mapping is present, so exposure must be confirmed against the affected product and deployment inventory.
Review the upstream advisory, identify the affected product in your inventory, and apply the vendor update when one is available.
Command Injection describes the vulnerability class recorded for this advisory. The current record does not mark CVE-2020-27575 as known exploited; continue to monitor the source for status changes. This is a product-level record in the current feed, not a package-level dependency mapping.
Affected software not mapped. Review the upstream record for vendor-specific product and version guidance.
Maxum Rumpus 8.2.13 and 8.2.14 is affected by a command injection vulnerability. The web administration contains functionality in which administrators are able to manage users. The edit users form contains a parameter vulnerable to command injection due to insufficient validation.
Reported by NVD (nvd).
CVE-2020-27575 records a High severity (CVSS 8.8) command injection vulnerability in CVE-2020-27575. The source record does not mark it as known exploited. No package mapping is present, so exposure must be confirmed against the affected product and deployment inventory.
The source record does not mark it as known exploited.
Confirm whether the product or interface named by this advisory exists in your inventory.
HOL Guard can help your team monitor supply-chain activity while the upstream record is clarified.
Explore HOL GuardReview the upstream advisory, identify the affected product in your inventory, and apply the vendor update when one is available.
Command Injection describes the vulnerability class recorded for this advisory. The current record does not mark CVE-2020-27575 as known exploited; continue to monitor the source for status changes. This is a product-level record in the current feed, not a package-level dependency mapping.
Affected software not mapped. Review the upstream record for vendor-specific product and version guidance.
Maxum Rumpus 8.2.13 and 8.2.14 is affected by a command injection vulnerability. The web administration contains functionality in which administrators are able to manage users. The edit users form contains a parameter vulnerable to command injection due to insufficient validation.
Reported by NVD (nvd).
CVE-2020-27575 records a High severity (CVSS 8.8) command injection vulnerability in CVE-2020-27575. The source record does not mark it as known exploited. No package mapping is present, so exposure must be confirmed against the affected product and deployment inventory.
The source record does not mark it as known exploited.
Confirm whether the product or interface named by this advisory exists in your inventory.
HOL Guard can help your team monitor supply-chain activity while the upstream record is clarified.
Explore HOL Guard